Cytokinetics Inc. buy The Goldman Sachs Group, Inc.
Start price
09.11.23
/
50%
€31.60
Target price
09.11.24
€46.68
Performance (%)
74.05%
End price
10.11.24
€55.00
Summary
This prediction ended on 10.11.24 with a price of €55.00. The BUY prediction by The_Goldman_Sachs_Gr for Cytokinetics Inc. saw massive gains of 74.05%. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | 1.463% | 1.463% | 104.294% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $50.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Stopped prediction by The_Goldman_Sachs_Gr for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€38.80
02.03.23
02.03.23
€45.28
02.03.24
02.03.24
71.39%
03.03.24
03.03.24
